We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Argento Labs, a UK-based biotech company, is dedicated to converting waste into valuable resources, leading the way in sustainable innovation. They utilize patented bioprocessing technology to extract sugars, proteins, and fats from agricultural, forestry, and municipal waste. Their product range includes alternative proteins, biogenic CO2, and bio-fertilizers, contributing to environmental sustainability and decarbonization efforts. Argento Labs focuses on scalability for industrial production to support a sustainable future and envisions waste as a transformative solution for preserving the planet. Their patent currently applies in the US jurisdiction.
days to go: Expired investment: £415,233
Antaco is a clean technology company that has come up with a solution to process any type of organic waste, both wet & dry (including woody), into a solid biofuel and a direct replacement for fossil coal. The company aims to disrupt current methods of organic waste disposal. Antaco won the 2013 Shell Springboard & 2014 WEX Technology Awards. It has received an £857,000 grant from the UK government and was voted the top UK & EU Cleantech start-up by Climate-KIC & EIT (European Institute of Technology & Innovation) in 2013. Antaco is seeking £400,000 (Future Fund matched) in further investment to expand operational capacity on-site, build its team, and capitalise on growing market opportunities.
days to go: Expired investment: £661,410
Doctors available 24 hours a day, 365 days a year to visit, diagnose, treat, refer and prescribe medication as needed. No membership fees or hidden costs.
days to go: Expired investment: £540,695
Delivering safe and clean drinking water by using nanotechnology to produce eco-friendly and recyclable filters. Water to Go has developed a portable 750ml filter that is equivalent to using more than 400 water bottles designed for single-use and made from plastic. Water to Go's technology has been tested in multiple laboratories across the globe and the company has planned to integrate their product into more applications. Their filter initially launched on Amazon.com and is currently available in over 50 countries worldwide. Clients include Boots, Millets, Go Outdoors and Blacks amongst others. Repeat sales of the filter is currently the main source of revenue.
days to go: Expired investment: £276,580
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go: Expired investment: £2,005,050
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £691,497
Please watch the video for more information
days to go: Expired investment: £257,501
Riversimple’s purpose it to pursue systemically the elimination of the environmental impact of personal transport.  They manufacture and develop environmentally friendly, clean, safe and fun hydrogen cars.  Their business model of a "sale of service contract" will mean they never sell a car and customers will have a contract of 1-3 years to include the cover of insurance and fuel.  They plan to trial 20 Rasa cars over 12 months in Monmouthshire and are crowdfunding to raise funds towards the build of 10 Beta cars.
days to go: Expired investment: £1,101,348
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph